Lv3
350 积分 2025-10-14 加入
Teprotumumab Use in Thyroid Eye Disease: Clinical Outcomes in the United Arab Emirates– a First Regional Case Series
6天前
已完结
Teprotumumab treatment for dysthyroid optic neuropathy
6天前
已完结
Beyond the Eyes: Is Teprotumumab Effective for Thyroid Dermopathy?
14天前
已完结
Efficacy of tocilizumab in patients with moderate-to-severe corticosteroid-resistant thyroid eye disease: a prospective study
21天前
已完结
Tocilizumab use for optic nerve compression in thyroid eye disease: a prospective longitudinal cohort
21天前
已完结
Medical Therapy in Patients with Moderate to Severe, Steroid-Resistant, Thyroid Eye Disease
21天前
已完结
Outcome of tocilizumab treatment in corticosteroid-resistant thyroid eye disease
24天前
已完结
Tocilizumab for the Management of Thyroid-Associated Orbitopathy
24天前
已完结
Efficacy and safety of Tocilizumab for thyroid eye disease: a systemic review and Meta-analysis
24天前
已完结
Thyroid eye disease (Graves' orbitopathy): clinical presentation, epidemiology, pathogenesis, and management
27天前
已完结
皖公网安备34019202002308
